Trial Summary
What is the purpose of this trial?
This trial will test a new harm reduction kiosk called KyOSK in rural Appalachia to help people who use drugs stay safer. The kiosk provides clean needles and other supplies to reduce the risk of HIV, hepatitis C, and overdoses. The study aims to determine if this new approach is more effective and cost-efficient.
Research Team
April M Young, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for adults over 18 living in specific Kentucky counties who've used drugs (other than marijuana, alcohol, and tobacco) to get high via injection or other methods in the past 6 months. It's not open to those under 18 or outside these areas.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Harm reduction kiosk (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
April M Young
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Dr. Nora Volkow
National Institute on Drug Abuse (NIDA)
Chief Executive Officer since 2003
MD from National Autonomous University of Mexico
Dr. Nora Volkow
National Institute on Drug Abuse (NIDA)
Chief Medical Officer since 2003
MD from National Autonomous University of Mexico